American Chemical Society - 237th national meeting & exposition. Part 1.
Thomson Reuters, 77 Hatton Garden, London EC1N 8JS, UK. claire.veryard@thomson.com
Claire
C
Veryard
D000700:Analgesics / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D015195:Drug Design; D004353:Drug Evaluation, Preclinical; D004345:Drug Industry; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology / Q000627:therapeutic use; D009140:Musculoskeletal Diseases / Q000188:drug therapy / Q000201:enzymology; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology / Q000627:therapeutic use
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D000970:Antineoplastic Agents; D000998:Antiviral Agents; D007004:Hypoglycemic Agents; D010975:Platelet Aggregation Inhibitors